About Index Trending news
Lists
Pricing
Epidarex Capital

Epidarex Capital

Epidarex Capital

Epidarex Capital (formerly Rock Spring Ventures) invests in earlystage, high growth life science and health technology companies in underventured markets within the UK and US.

Elsewhere

Alexa global traffic share

Activity

Past year's investments

Epidarex Capital participated in fewer than 3 rounds over the past year

Latest rounds
  • Apellis Pharma: Venture capital (Series E) ($60M)
  • Eternygen GmbH: Venture capital (Series A) (€8M)
  • Enterprise Therapeutics: Venture capital (£4M)
Total funding
$4.8M in 1 rounds from 1 investors
By Epidarex Capital
$4.8M Series A in Dec, 2014
Total funding
$139.1M in 3 rounds from 16 investors
By Epidarex Capital
$60M Series E in Aug, 2017
Total funding
$15.2M in 1 rounds from 3 investors
By Epidarex Capital
€14M Series A in Mar, 2016
Total funding
$15.2M in 1 rounds from 4 investors
By Epidarex Capital
€14M Series A in Mar, 2016
Total funding
$6.2M in 1 rounds from 2 investors
By Epidarex Capital
$6.2M Series A in Jun, 2016
Total funding
$7.3M in 3 rounds from 4 investors
By Epidarex Capital
£4M Venture Capital in Nov, 2016
Total funding
$8.4M in 1 rounds from 3 investors
By Epidarex Capital
€8M Series A in Jan, 2017

Want to see the complete list?
Go Pro!